Edition:
United States

ITUS Corp (ITUS.OQ)

ITUS.OQ on NASDAQ Stock Exchange Capital Market

4.94USD
10:35am EDT
Change (% chg)

$0.27 (+5.78%)
Prev Close
$4.67
Open
$4.66
Day's High
$4.94
Day's Low
$4.66
Volume
4,610
Avg. Vol
20,747
52-wk High
$6.42
52-wk Low
$1.83

Chart for

About

ITUS Corporation is engaged in developing a diagnostic platform called Cchek, for the early detection of tumor-based cancers. The Cchek cancer detection platform measures a patient's immune response to a malignancy by detecting the presence, absence and quantity of certain immune cells that exist in and around a tumor and that... (more)
No analyst recommendations are available for .

Overall

Beta: -0.60
Market Cap(Mil.): $87.31
Shares Outstanding(Mil.): 18.70
Dividend: --
Yield (%): --

Financials

  ITUS.OQ Industry Sector
P/E (TTM): -- 29.91 24.15
EPS (TTM): -0.60 -- --
ROI: -180.08 9.42 7.81
ROE: -177.40 13.57 12.97

BRIEF-Itus Corp - Co Entered Into An At Market Issuance Sales Agreement With B. Riley FBR, Inc

* ITUS CORP - ‍ON MARCH 27, CO ENTERED INTO AN AT MARKET ISSUANCE SALES AGREEMENT WITH B. RILEY FBR, INC TO CREATE AN AT MARKET EQUITY PROGRAM​

Mar 27 2018

BRIEF-Itus And Serametrix Announce Results Of A Blinded Prostate Cancer Study

* ITUS AND SERAMETRIX ANNOUNCE RESULTS OF A BLINDED PROSTATE CANCER STUDY

Mar 27 2018

Earnings vs. Estimates

No consensus analysis data available.